Emeryville cancer drug developer lands $21M from Chinese, other investors

Cancer therapy developer Eureka Therapeutics Inc. snagged $21 million in a Series C round led by Chinese private equity firm Yuan Capital...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.